Cutaneous pseudolymphomas: inflammatory reactive proliferations

References

• Hussein MR. Atypical lymphoid proliferations: the pathologist’s viewpoint. Expert Rev. Hematol. 6(2), 139–53 (2013).
   PubMed Web of Science ®Google Scholar
• Egbers RG, Do TT, Su L, Helfrich YR, Gudjonsson JE. Rapid clinical change in lesions of atypical cutaneous lymphoproliferative disorder in an HIV patient: a case report and review of the literature. Dermatol. Online J. 17(9), 4 (2011).
   PubMedGoogle Scholar
• Pirovano S, Signorini L, Facchetti F, Santoro A, Albertin A, Imberti L. Polyclonal T-cell expansions in a HIV(+) patient with atypical cutaneous lymphoproliferative disorder, large granular lymphocyte proliferation and SENV infection. Haematologica 86(8), 881–882 (2001).
   PubMed Web of Science ®Google Scholar
• Friedler S, Parisi MT, Waldo E, Wieczorek R, Sidhu G, Rico MJ. Atypical cutaneous lymphoproliferative disorder in patients with HIV infection. Int. J. Dermatol. 38(2), 111–118 (1999).
   PubMed Web of Science ®Google Scholar
• Burg G, Kerl H, Schmoeckel C. Differentiation between malignant B-cell lymphomas and pseudolymphomas of the skin. J. Dermatol. Surg. Oncol. 10(4), 271–275 (1984).
   PubMedGoogle Scholar
• Becker H. [Reactive lymphadenopathy-enlargement-pseudolymphoma--prelymphoma]. Fortschr. Med. 98(35), 1322–4, 1326–7 (1980).
   PubMedGoogle Scholar
• Nihal M, Mikkola D, Horvath N et al. Cutaneous lymphoid hyperplasia: a lymphoproliferative continuum with lymphomatous potential. Hum. Pathol. 34(6), 617–622 (2003).
   PubMed Web of Science ®Google Scholar
• Egawa G and Kabashima K. Skin as a peripheral lymphoid organ: revisiting the concept of skin-associated lymphoid tissues. J. Invest. Dermatol. 131(11), 2178–2185 (2011).
   PubMed Web of Science ®Google Scholar
• Wolfle U, Martin S, Emde M, Schempp C. Dermatology in the Darwin anniversary. Part 2: evolution of the skin-associated immune system. J. Dtsch. Dermatol. Ges. 7(10), 862–869 (2009).
   PubMed Web of Science ®Google Scholar
• Streilein JW. Skin-associated lymphoid tissues (SALT): origins and functions. J. Invest. Dermatol. 80(Suppl.), S12–S16 (1983).
   Google Scholar
• Streilein JW. Circuits and signals of the skin-associated lymphoid tissues (SALT). J. Invest. Dermatol. 85( Suppl. 1), S10–S13 (1985).
   Web of Science ®Google Scholar
• Streilein JW. Sunlight and skin-associated lymphoid tissues (SALT): if UVB is the trigger and TNF alpha is its mediator, what is the message? J. Invest. Dermatol. 100(1), S47–S52 (1993).
   PubMed Web of Science ®Google Scholar
• Wirt DP, Grogan TM, Jolley CS et al. The immunoarchitecture of cutaneous pseudolymphoma. Hum. Pathol. 16(5), 492–510 (1985).
   PubMed Web of Science ®Google Scholar
• Picker LJ, Treer JR, Ferguson-Darnell B, Collins PA, Bergstresser PR, Terstappen LW. Control of lymphocyte recirculation in man. II. Differential regulation of the cutaneous lymphocyte-associated antigen, a tissue-selective homing receptor for skin-homing T cells. J. Immunol. 150(3), 1122–1136 (1993).
   PubMed Web of Science ®Google Scholar
• Akdis M, Simon HU, Weigl L, Kreyden O, Blaser K, Akdis CA. Skin homing (cutaneous lymphocyte-associated antigen-positive) CD8+ T cells respond to superantigen and contribute to eosinophilia and IgE production in atopic dermatitis. J. Immunol. 163(1), 466–75 (1999).
   PubMed Web of Science ®Google Scholar
• Girardi M, Berger CL, Wilson LD et al. Transimmunization for cutaneous T cell lymphoma: a Phase I study. Leuk. Lymphoma 47(8), 1495–503 (2006).
   PubMed Web of Science ®Google Scholar
• Schon MP, Ludwig RJ. Lymphocyte trafficking to inflamed skin--molecular mechanisms and implications for therapeutic target molecules. Expert Opin. Ther. Targets 9(2), 225–243 (2005).
   PubMed Web of Science ®Google Scholar
• Williams IR, Kupper TS. Immunity at the surface: homeostatic mechanisms of the skin immune system. Life Sci. 58(18), 1485–1507 (1996).
   PubMed Web of Science ®Google Scholar
• Bachelez H. The uncertain status of cutaneous pseudolymphoma. Actas Dermosifiliogr. 100( Suppl. 1), 33–37 (2009).
   Google Scholar
• Luelmo Aguilar J, Mieras Barcelo C, Martin-Urda MT, Castells Rodellas A, Lecha Carralero M, Marti Laborda R. Generalized cutaneous B-cell pseudolymphoma induced by neuroleptics. Arch. Dermatol. 128(1), 121–123 (1992).
   PubMedGoogle Scholar
• Mittal RR, Jain C, Walia RL, Chopra A. Drug-induced pseudolymphoma syndrome. Indian J. Dermatol. Venereol. Leprol. 61(2), 94–95 (1995).
   PubMedGoogle Scholar
• Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). Semin. Cutan. Med Surg. 15(4), 250–257 (1996).
   PubMed Web of Science ®Google Scholar
• Callot V, Roujeau JC, Bagot M et al. Drug-induced pseudolymphoma and hypersensitivity syndrome. Two different clinical entities. Arch. Dermatol. 132(11), 1315–1321(1996).
   PubMedGoogle Scholar
• Paley K, Geskin LJ, Zirwas MJ. Cutaneous B-cell pseudolymphoma due to paraphenylenediamine. Am J Dermatopathol. 28(5), 438–441(2006).
   PubMed Web of Science ®Google Scholar
• Stavrianeas NG, Katoulis AC, Bozi E et al. Cutaneous pseudolymphoma following administration of lornoxicam. Acta Derm. Venereol. 87(5), 453–455 (2007).
   PubMed Web of Science ®Google Scholar
• Fukamachi S, Sugita K, Nakamura M, Tokura Y. Cutaneous pseudolymphoma due to benidipine hydrochloride with massive infiltration of eosinophils. J. Dermatol. 38(9), 935–937 (2011).
   PubMed Web of Science ®Google Scholar
• Campolmi P, Bassi A, Bonan P et al. Cutaneous pseudolymphoma localized to black tattoo. J. Am. Acad. Dermatol. 65(5), e155–e157 (2011).
   PubMedGoogle Scholar
• Camilot D, Arnez ZM, Luzar B, Pizem J, Zgavec B, Falconieri G. Cutaneous pseudolymphoma following tattoo application: report of two new cases of a potential lymphoma mimicker. Int. J. Surg. Pathol. 20(3), 311–315 (2012).
   PubMed Web of Science ®Google Scholar
• Imafuku S, Ito K, Nakayama J. Cutaneous pseudolymphoma induced by adalimumab and reproduced by infliximab in a patient with arthropathic psoriasis. Br. J. Dermatol. 166(3), 675–678 (2012).
   PubMed Web of Science ®Google Scholar
• von Orelli S, Schnarwyler B, Maurer R, Hirsch H, von Castelberg B. [Vulvar pseudolymphoma: detection of infection by Borrelia burgdorferi using polymerase chain reaction]. Gynakol. Geburtshilfliche Rundsch. 38(3), 143–145 (1998).
   PubMedGoogle Scholar
• Ziemer M, Eisendle K, Muller H, Zelger B. Lymphocytic infiltration of the skin (Jessner-Kanof) but not reticular erythematous mucinosis occasionally represents clinical manifestations of Borrelia-associated pseudolymphoma. Br. J. Dermatol. 161(3), 583–590 (2009).
   PubMed Web of Science ®Google Scholar
• Lin JJ, Farha GJ, Taylor RJ. Pseudolymphoma of the breast. I. In a study of 8,654 consecutive tylectomies and mastectomies. Cancer 45(5), 973–978 (1980).
   PubMed Web of Science ®Google Scholar
• Cherubini M, Rizzardi C, Melato M. [Pseudolymphoma of the breast involving the periareolar area]. Chir. Ital. 53(5), 689–695 (2001).
   PubMedGoogle Scholar
• Boudova L, Kazakov DV, Hes O et al. [Pseudolymphoma of the breast nipple. The problem overview]. Rozhl. Chir. 84(2), 66–69 (2005).
   PubMedGoogle Scholar
• Narain S, Eva L, Luesley D. A rare case of pseudolymphoma of the vulva. J. Obstet. Gynaecol. 29(3), 254–255 (2009).
   PubMedGoogle Scholar
• Braun RP, French LE, Feldmann R, Chavaz P, Saurat JH. Cutaneous pseudolymphoma, lymphomatoid contact dermatitis type, as an unusual cause of symmetrical upper eyelid nodules. Br. J. Dermatol. 143(2), 411–414 (2000).
   PubMed Web of Science ®Google Scholar
• Cloke A, Lim LT, Crofts KP. Cutaneous pseudolymphoma: an unusual eyelid presentation. Semin. Ophthalmol. 27(1–2), 35–36 (2012).
   PubMed Web of Science ®Google Scholar
• Nnebe NV, Woon C, Haines S, Dayton V, Weigel BJ. Cutaneous pseudolymphoma: an unusual presentation of a scalp mass. Pediatr. Blood Cancer 52(2), 283–285 (2009).
   PubMed Web of Science ®Google Scholar
• Zinberg M, Heilman E, Glickman F. Cutaneous pseudolymphoma resulting from a tattoo. J. Dermatol. Surg. Oncol. 8(11), 955–8 (1982).
   PubMedGoogle Scholar
• Gutermuth J, Hein R, Fend F, Ring J, Jakob T. Cutaneous pseudolymphoma arising after tattoo placement. J. Eur. Acad. Dermatol. Venereol. 21(4), 566–567 (2007).
   PubMed Web of Science ®Google Scholar
• Chiang C, Romero L. Cutaneous lymphoid hyperplasia (pseudolymphoma) in a tattoo after far infrared light. Dermatol. Surg. 35(9), 1434–1438 (2009).
   PubMed Web of Science ®Google Scholar
• Shin JB, Seo SH, Kim BK, Kim IH, Son SW. Cutaneous T cell pseudolymphoma at the site of a semipermanent lip-liner tattoo. Dermatology 218(1), 75–78 (2009).
   PubMed Web of Science ®Google Scholar
• Kluger N, Vermeulen C, Moguelet P et al. Cutaneous lymphoid hyperplasia (pseudolymphoma) in tattoos: a case series of seven patients. J. Eur. Acad. Dermatol. Venereol. 24(2), 208–213 (2010).
   PubMed Web of Science ®Google Scholar
• Lanzafame S, Micali G. [Cutaneous lymphoid hyperplasia (pseudolymphoma) secondary to vaccination]. Pathologica 85(1099), 555–561 (1993).
   PubMedGoogle Scholar
• Maubec E, Pinquier L, Viguier M et al. Vaccination-induced cutaneous pseudolymphoma. J. Am. Acad. Dermatol. 52(4), 623–629 (2005).
   PubMed Web of Science ®Google Scholar
• Cerroni L, Borroni RG, Massone C, Chott A, Kerl H. Cutaneous B-cell pseudolymphoma at the site of vaccination. Am. J. Dermatopathol. 29(6), 538–542 (2007).
   PubMed Web of Science ®Google Scholar
• Bueno MJ, Perez de Castro I, Gomez de Cedron M et al. Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. Cancer Cell 13(6), 496–506 (2008).
   PubMed Web of Science ®Google Scholar
• Guillard O, Fauconneau B, Pineau A, Marrauld A, Bellocq JP, Chenard MP. Aluminium overload after 5 years in skin biopsy following post-vaccination with subcutaneous pseudolymphoma. J. Trace Elem. Med. Biol. 26(4), 291–293 (2012).
   PubMed Web of Science ®Google Scholar
• Sexton M. Occult herpesvirus folliculitis clinically simulating pseudolymphoma. Am. J. Dermatopathol. 13(3), 234–240 (1991).
   PubMed Web of Science ®Google Scholar
• Arai E, Okubo H, Tsuchida T, Kitamura K, Katayama I. Pseudolymphomatous folliculitis: a clinicopathologic study of 15 cases of cutaneous pseudolymphoma with follicular invasion. Am. J. Surg. Pathol. 23(11), 1313–1319 (1999).
   PubMed Web of Science ®Google Scholar
• Dargent JL, Debois J, Sass U, Theunis A, Andre J, Simonart T. Unusual T cell pseudolymphoma with features of so-called pseudolymphomatous folliculitis. Dermatology 204(2), 159–161 (2002).
   PubMed Web of Science ®Google Scholar
• Schmid U, Eckert F, Griesser H et al. Cutaneous follicular lymphoid hyperplasia with monotypic plasma cells. A clinicopathologic study of 18 patients. Am. J. Surg. Pathol. 19(1), 12–20 (1995).
   PubMed Web of Science ®Google Scholar
• Cerroni L, Arzberger E, Putz B et al. Primary cutaneous follicle center cell lymphoma with follicular growth pattern. Blood 95(12), 3922–3928 (2000).
   PubMed Web of Science ®Google Scholar
• Nakajima T, Sano S, Itami S, Yoshikawa K. Cutaneous inflammatory pseudotumour (plasma cell granuloma). Br. J. Dermatol. 144(6), 1271–1273 (2001).
   PubMed Web of Science ®Google Scholar
• Chen YF, Chao CM, Liu HN. Cutaneous plasma cell granuloma: report of a case with novel histologic and immunohistochemical findings. Int. J. Dermatol. 48(4), 409–411 (2009).
   PubMed Web of Science ®Google Scholar
• Ramsay B, Dahl MC, Malcolm AJ, Wilson-Jones E. Acral pseudolymphomatous angiokeratoma of children. Arch. Dermatol. 126(11), 1524–1525 (1990).
   PubMedGoogle Scholar
• Hara M, Matsunaga J, Tagami H. Acral pseudolymphomatous angiokeratoma of children (APACHE): a case report and immunohistological study. Br. J. Dermatol. 124(4), 387–388 (1991).
   PubMed Web of Science ®Google Scholar
• Murakami T, Ohtsuki M, Nakagawa H. Acral pseudolymphomatous angiokeratoma of children: a pseudolymphoma rather than an angiokeratoma. Br. J. Dermatol. 145(3), 512–514 (2001).
   PubMed Web of Science ®Google Scholar
• Okuda C, Ito K, Ito M. Acral pseudolymphomatous angiokeratoma of children: a case with a lesion on the wrist. Acta Derm. Venereol. 82(4), 301–302 (2002).
   PubMed Web of Science ®Google Scholar
• Hagari Y, Hagari S, Kambe N, Kawaguchi T, Nakamoto S, Mihara M. Acral pseudolymphomatous angiokeratoma of children: immunohistochemical and clonal analyses of the infiltrating cells. J. Cutan. Pathol. 29(5), 313–318 (2002).
   PubMed Web of Science ®Google Scholar
• Kiyohara T, Kumakiri M, Kawasaki T, Takeuchi A, Kuwahara H, Ueda T. Linear acral pseudolymphomatous angiokeratoma of children (APACHE): further evidence that APACHE is a cutaneous pseudolymphoma. J. Am. Acad. Dermatol. 48( 2 Suppl), S15–S17 (2003).
   PubMed Web of Science ®Google Scholar
• Lee MW, Choi JH, Sung KJ, Moon KC, Koh JK. Acral pseudolymphomatous angiokeratoma of children (APACHE). Pediatr. Dermatol. 20(5), 457–458 (2003).
   PubMed Web of Science ®Google Scholar
• Gansz B, Stander S, Metze D. [Acral pseudolymphomatous angiokeratoma of children (APACHE)]. Hautarzt 56(3), 270–272 (2005).
   PubMed Web of Science ®Google Scholar
• Kim SH, Min KS, Kim NH, Yoon JT. Differential expression of programmed cell death on the follicular development in normal and miniature pig ovary. PLoS One 7(10), e46194 (2012).
   PubMed Web of Science ®Google Scholar
• Chedraoui A, Malek J, Tamraz H, Zaynoun S, Kibbi AG, Ghosn S. Acral pseudolymphomatous angiokeratoma of children in an elderly man: report of a case and review of the literature. Int. J. Dermatol. 49(2), 184–188 (2010).
   PubMed Web of Science ®Google Scholar
• Tokuda Y, Arakura F, Murata H, Koga H, Kawachi S, Nakazawa K. Acral pseudolymphomatous angiokeratoma of children: a case report with immunohistochemical study of antipodoplanin antigen. Am. J. Dermatopathol. 34(8), e128–e132 (2012).
   PubMed Web of Science ®Google Scholar
• Dayrit JF, Wang WL, Goh SG, Ramdial PK, Lazar AJ, Calonje E. T-cell-rich angiomatoid polypoid pseudolymphoma of the skin: a clinicopathologic study of 17 cases and a proposed nomenclature. J Cutan Pathol. 38(6), 475–482 (2011).
   PubMed Web of Science ®Google Scholar
• Moulonguet I, Ghnassia M, Molina T, Fraitag S. Miliarial-type perifollicular B-cell pseudolymphoma (lymphocytoma cutis): a misleading eruption in two women. J. Cutan Pathol. 39(11), 1016–1021 (2012).
   PubMed Web of Science ®Google Scholar
• Cheuk W, Lee KC, Chong LY, Yuen ST, Chan JK. IgG4-related Sclerosing disease: a potential new etiology of cutaneous pseudolymphoma. Am. J. Surg. Pathol. 33(11), 1713–1719 (2009).
   PubMed Web of Science ®Google Scholar
• Rijlaarsdam JU, Willemze R. Cutaneous pseudolymphomas: classification and differential diagnosis. Semin. Dermatol. 13(3), 187–196 (1994).
   PubMedGoogle Scholar
• Cerroni L and Kerl H. Diagnostic immunohistology: cutaneous lymphomas and pseudolymphomas. Semin. Cutan. Med. Surg. 18(1), 64–70 (1999).
   PubMed Web of Science ®Google Scholar
• Ide F, Shimoyama T, Horie N. Plasma cell granuloma of the oral mucosa with angiokeratomatous features: a possible analogue of cutaneous angioplasmocellular hyperplasia. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 89(2), 204–207 (2000).
   PubMed Web of Science ®Google Scholar
• Kazakov DV, Burg G, Dummer R, Kempf W. Cutaneous lymphomas and pseudolymphomas: newly described entities. Recent Results Cancer Res. 160, 283–293 (2002).
   PubMedGoogle Scholar
• Kazakov DV, Burg G, Kempf W. Primary cutaneous B-cell lymphomas and pseudolymphomas: review of histopathological features. Cesk. Patol. 38(4), 147–154 (2002).
   PubMedGoogle Scholar
• Cerroni L, Goteri G. Differential diagnosis between cutaneous lymphoma and pseudolymphoma. Anal. Quant. Cytol. Histol. 25(4), 191–198 (2003).
   PubMedGoogle Scholar
• Moreno-Ramirez D, Garcia-Escudero A, Rios-Martin JJ, Herrera-Saval A, Camacho F. Cutaneous pseudolymphoma in association with molluscum contagiosum in an elderly patient. J Cutan Pathol. 30(7), 473–475 (2003).
   PubMed Web of Science ®Google Scholar
• Lee MW, Choi JH, Sung KJ, Moon KC, Koh JK. A case of cutaneous pseudolymphoma associated with silicone injection. Acta. Derm. Venereol. 84(4), 312–313 (2004).
   PubMed Web of Science ®Google Scholar
• Lee MW, Lee DK, Choi JH, Moon KC, Koh JK. Clinicopathologic study of cutaneous pseudolymphomas. J. Dermatol. 32(7), 594–601 (2005).
   PubMed Web of Science ®Google Scholar
• Del Boz Gonzalez J, Sanz A, Martin T, Samaniego E, Martinez S, Crespo V. Cutaneous pseudolymphoma associated with molluscum contagiosum: a case report. Int. J. Dermatol. 47(5), 502–504 (2008).
   PubMed Web of Science ®Google Scholar
• Moon HS, Park K, Lee JH, Son SJ. A nodular syphilid presenting as a pseudolymphoma: mimicking a cutaneous marginal zone B-cell lymphoma. Am. J. Dermatopathol. 31(8), 846–848 (2009).
   PubMed Web of Science ®Google Scholar
• Berti E, Gianotti R, Alessi E, Caputo R. Primary cutaneous follicular center cell lymphoma: immunophenotypical and immunogenotypical aspects. Curr. Probl. Dermatol. 19, 196–202 (1990).
   PubMedGoogle Scholar
• Pimpinelli N, Santucci M, Carli P et al. Primary cutaneous follicular center cell lymphoma: clinical and histological aspects. Curr. Probl. Dermatol. 19, 203–220 (1990).
   PubMedGoogle Scholar
• Cerroni L, Kerl H. Cutaneous follicle center cell lymphoma, follicular type. Am. J. Dermatopathol. 23(4), 370–373 (2001).
   PubMed Web of Science ®Google Scholar
• Leinweber B, Colli C, Chott A, Kerl H, Cerroni L. Differential diagnosis of cutaneous infiltrates of B lymphocytes with follicular growth pattern. Am. J. Dermatopathol. 26(1), 4–13 (2004).
   PubMed Web of Science ®Google Scholar
• Spina D, Miracco C, Santopietro R et al. Distinction between diffuse cutaneous malignant follicular center cell lymphoma and lymphoid hyperplasia by computerized nuclear image analysis. Am. J. Dermatopathol. 15(5), 415–422 (1993).
   PubMed Web of Science ®Google Scholar
• Anghel G, Pulsoni A, De Rosa L. Primary cutaneous follicle center cell lymphoma and limited stage follicular non-Hodgkin’s lymphoma: a comparison of clinical and biological features. Leuk. Lymphoma 43(11), 2109–2115 (2002).
   PubMed Web of Science ®Google Scholar
• Goodlad JR, Krajewski AS, Batstone PJ et al. Primary cutaneous follicular lymphoma: a clinicopathologic and molecular study of 16 cases in support of a distinct entity. Am. J. Surg. Pathol. 26(6), 733–741 (2002).
   PubMed Web of Science ®Google Scholar
• Cerroni L, Volkenandt M, Rieger E, Soyer HP, Kerl H. bcl-2 protein expression and correlation with the interchromosomal 14;18 translocation in cutaneous lymphomas and pseudolymphomas. J. Invest. Dermatol. 102(2), 231–235 (1994).
   PubMed Web of Science ®Google Scholar
• Sroa N, Magro CM. Pediatric primary cutaneous marginal zone lymphoma: in association with chronic antihistamine use. J. Cutan. Pathol. 33(Suppl. 2), 1–5 (2006).
   Google Scholar
• Cerroni L, Signoretti S, Hofler G et al. Primary cutaneous marginal zone B-cell lymphoma: a recently described entity of low-grade malignant cutaneous B-cell lymphoma. Am. J. Surg. Pathol. 21(11), 1307–1315 (1997).
   PubMed Web of Science ®Google Scholar
• Baldassano MF, Bailey EM, Ferry JA, Harris NL, Duncan LM. Cutaneous lymphoid hyperplasia and cutaneous marginal zone lymphoma: comparison of morphologic and immunophenotypic features. Am. J. Surg. Pathol. 23(1), 88–96 (1999).
   PubMed Web of Science ®Google Scholar
• Cho-Vega JH, Vega F, Rassidakis G, Medeiros LJ. Primary cutaneous marginal zone B-cell lymphoma. Am. J. Clin. Pathol. 125(Suppl.), S38–S49 (2006).
   Google Scholar
• Takino H, Li C, Hu S et al. Primary cutaneous marginal zone B-cell lymphoma: a molecular and clinicopathological study of cases from Asia, Germany, and the United States. Mod. Pathol. 21(12), 1517–1526 (2008).
   PubMed Web of Science ®Google Scholar
• Edinger JT, Lorenzo CR, Breneman DL, Swerdlow SH. Primary cutaneous marginal zone lymphoma with subclinical cutaneous involvement and biclonality. J. Cutan. Pathol. 38(9), 724–730 (2011).
   PubMed Web of Science ®Google Scholar
• Terhune MH, Stibbe J, Siegle RJ. Nodule on the cheek of an 81-year-old woman. Persistent arthropod bite reaction (cutaneous T-cell pseudolymphoma). Arch. Dermatol. 135(12), 1543–1544, 1546–1547 (1999).
   PubMedGoogle Scholar
• Gilliam AC, Wood GS. Cutaneous lymphoid hyperplasias. Semin. Cutan. Med. Surg. 19(2), 133–141 (2000).
   PubMed Web of Science ®Google Scholar
• Mitani N, Nagatani T, Ikezawa Z et al. A case of cutaneous T cell pseudolymphoma in a patient with Helicobacter pylori infection. Dermatology 213(2), 156–158 (2006).
   PubMed Web of Science ®Google Scholar
• Smoller BR, Detwiler SP, Kohler S, Hoppe RT, Kim YH. Role of histology in providing prognostic information in mycosis fungoides. J. Cutan. Pathol. 25(6), 311–315 (1998).
   PubMed Web of Science ®Google Scholar
• Massone C, Kodama K, Kerl H, Cerroni L. Histopathologic features of early (patch) lesions of mycosis fungoides: a morphologic study on 745 biopsy specimens from 427 patients. Am. J. Surg. Pathol. 29(4), 550–560 (2005).
   PubMed Web of Science ®Google Scholar
• Ortonne N, Buyukbabani N, Delfau-Larue MH, Bagot M, Wechsler J. Value of the CD8-CD3 ratio for the diagnosis of mycosis fungoides. Mod. Pathol. 16(9), 857–862 (2003).
   PubMed Web of Science ®Google Scholar
• Medeiros LJ, Picker LJ, Abel EA et al. Cutaneous lymphoid hyperplasia. Immunologic characteristics and assessment of criteria recently proposed as diagnostic of malignant lymphoma. J. Am. Acad. Dermatol. 21(5 Pt 1), 929–942 (1989).
   PubMed Web of Science ®Google Scholar
• Ormsby A, Bergfeld WF, Tubbs RR, Hsi ED. Evaluation of a new paraffin-reactive CD7 T-cell deletion marker and a polymerase chain reaction-based T-cell receptor gene rearrangement assay: implications for diagnosis of mycosis fungoides in community clinical practice. J. Am. Acad. Dermatol. 45(3), 405–413 (2001).
   PubMed Web of Science ®Google Scholar
• Cotta AC, Cintra ML, de Souza EM et al. Diagnosis of mycosis fungoides: a comparative immunohistochemical study of T-cell markers using a novel anti-CD7 antibody. Appl. Immunohistochem. Mol. Morphol. 14(3), 291–295 (2006).
   PubMedGoogle Scholar
• Bakels V, van Oostveen JW, van der Putte SC, Meijer CJ, Willemze R. Immunophenotyping and gene rearrangement analysis provide additional criteria to differentiate between cutaneous T-cell lymphomas and pseudo-T-cell lymphomas. Am. J. Pathol. 150(6), 1941–1949 (1997).
   PubMed Web of Science ®Google Scholar
• Tirumalae R, Panjwani PK. Origin Use of CD4, CD8, and CD1a immunostains in distinguishing mycosis fungoides from its inflammatory mimics: A Pilot Study. Indian J. Dermatol. 57(6), 424–427 (2012).
   PubMedGoogle Scholar
• Sangueza OP, Yadav S, White CR Jr, Braziel RM. Evolution of B-cell lymphoma from pseudolymphoma. A multidisciplinary approach using histology, immunohistochemistry, and Southern blot analysis. Am. J. Dermatopathol. 14(5), 408–413 (1992).
   PubMed Web of Science ®Google Scholar
• Pecorari P, Rizzardi C, Melato M. Cutaneous pseudolymphoma of the breast with late homozonal relapse. Oncol. Rep. 8(4), 913–915 (2001).
   PubMed Web of Science ®Google Scholar
• Kulow BF, Cualing H, Steele P et al. Progression of cutaneous B-cell pseudolymphoma to cutaneous B-cell lymphoma. J. Cutan. Med. Surg. 6(6), 519–528 (2002).
   PubMed Web of Science ®Google Scholar
• Beltraminelli H, Leinweber B, Kerl H, Cerroni L. Primary cutaneous CD4+ small-/medium-sized pleomorphic T-cell lymphoma: a cutaneous nodular proliferation of pleomorphic T lymphocytes of undetermined significance? A study of 136 cases. Am. J. Dermatopathol. 31(4), 317–322 (2009).
   PubMed Web of Science ®Google Scholar
• Beltraminelli H, Mullegger R, Cerroni L. Indolent CD8+ lymphoid proliferation of the ear: a phenotypic variant of the small-medium pleomorphic cutaneous T-cell lymphoma? J. Cutan. Pathol. 37(1), 81–84 (2010).
   PubMed Web of Science ®Google Scholar
• Rodriguez Pinilla SM, Roncador G, Rodriguez-Peralto JL et al. Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma expresses follicular T-cell markers. Am. J. Surg. Pathol. 33(1), 81–90 (2009).
   PubMed Web of Science ®Google Scholar
• Cetinozman F, Jansen PM, Willemze R. Expression of programmed death-1 in primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoma, cutaneous pseudo-T-cell lymphoma, and other types of cutaneous T-cell lymphoma. Am. J. Surg. Pathol. 36(1), 109–116 (2012).
   PubMed Web of Science ®Google Scholar
• Wang SS, Davis S, Cerhan JR et al. Polymorphisms in oxidative stress genes and risk for non-Hodgkin lymphoma. Carcinogenesis 27(9), 1828–1234 (2006).
   PubMed Web of Science ®Google Scholar
• Kiessling MK, Klemke CD, Kaminski MM, Galani IE, Krammer PH, Gulow K. Inhibition of constitutively activated nuclear factor-kappaB induces reactive oxygen species- and iron-dependent cell death in cutaneous T-cell lymphoma. Cancer Res. 69(6), 2365–74 (2009).
   PubMed Web of Science ®Google Scholar
• Bouloc A, Delfau-Larue MH, Lenormand B et al. Polymerase chain reaction analysis of immunoglobulin gene rearrangement in cutaneous lymphoid hyperplasias. French Study Group for Cutaneous Lymphomas. Arch. Dermatol. 135(2), 168–172 (1999).
   PubMedGoogle Scholar
• Peris K, Cerroni L, Kerl H, Radaszkiewicz T, Chimenti S, Hofler H. Expression of c-myc in cutaneous lymphomas and pseudolymphomas. Dermatologica 183(1), 1–6 (1991).
   PubMedGoogle Scholar
• Peris K, Niedermeyer H, Cerroni L, Radaskiewicz T, Chimenti S, Hofler H. Detection of Epstein-Barr virus genome in primary cutaneous T and B cell lymphomas and pseudolymphomas. Arch. Dermatol. Res. 286(7), 364–368 (1994).
   PubMed Web of Science ®Google Scholar
• Wagner M, Rose VA, Linder R, Schulze HJ, Krueger GR. Human pathogenic virus-associated pseudolymphomas and lymphomas with primary cutaneous manifestation in humans and animals. Clin. Infect. Dis. 27(5), 1299–1308 (1998).
   PubMed Web of Science ®Google Scholar
• Bachelez H, Hadida F, Parizot C et al. Oligoclonal expansion of HIV-specific cytotoxic CD8 T lymphocytes in the skin of HIV-1-infected patients with cutaneous pseudolymphoma. J. Clin. Invest. 101(11), 2506–2516 (1998).
   PubMed Web of Science ®Google Scholar
• Landa NG, Zelickson BD, Peters MS, Muller SA, Pittelkow MR. Lymphoma versus pseudolymphoma of the skin: gene rearrangement study of 21 cases with clinicopathologic correlation. J. Am. Acad. Dermatol. 29(6), 945–953 (1993).
   PubMed Web of Science ®Google Scholar
• Adams JD. Localized cutaneous pseudolymphoma associated with phenytoin therapy: a case report. Australas. J. Dermatol. 22(1), 28–29 (1981).
   PubMedGoogle Scholar
• Thestrup-Pedersen K, Zachariae C, Kaltoft K, Pallesen G, Sogaard H. Development of cutaneous pseudolymphoma following ciclosporin therapy of actinic reticuloid. Dermatologica 177(6), 376–81 (1988).
   PubMedGoogle Scholar
• Blazejak T, Holzle E. [Phenothiazine-induced pseudolymphoma]. Hautarzt 41(3), 161–163 (1990).
   PubMed Web of Science ®Google Scholar
• Delaporte E, Catteau B, Cardon T et al. [Cutaneous pseudolymphoma during treatment of rheumatoid polyarthritis with low-dose methotrexate]. Ann. Dermatol. Venereol. 122(8), 521–525 (1995).
   PubMed Web of Science ®Google Scholar
• d’Incan M, Mouillet ML, Roger H et al. [Cutaneous pseudolymphoma caused by carbamazepine]. Ann. Dermatol. Venereol. 125(1), 52–55 (1998).
   PubMed Web of Science ®Google Scholar
• Wiesli P, Joos L, Galeazzi RL, Dummer R. Cutaneous pseudolymphoma associated with bromocriptine therapy. Clin. Endocrinol (Oxf). 53(5), 656–657 (2000).
   PubMed Web of Science ®Google Scholar
• Cogrel O, Beylot-Barry M, Vergier B et al. Sodium valproate-induced cutaneous pseudolymphoma followed by recurrence with carbamazepine. Br. J. Dermatol. 144(6), 1235–1238 (2001).
   PubMed Web of Science ®Google Scholar
• Dar NR, Shaheen, Mustafvi SA, Raza N. Cutaneous pseudolymphoma due to topical application of 4% hydroquinone cream for melasma. J. Coll. Physicians Surg. Pak. 15(8), 496–497 (2005).
   PubMedGoogle Scholar
• Guis S, Schiano de Colella JM, Bonnet N et al. Cutaneous pseudolymphoma associated with a TNF-alpha inhibitor treatment: etanercept. Eur. J. Dermatol. 18(4), 474–476 (2008).
   PubMed Web of Science ®Google Scholar
• Kitagawa KH, Grassi M. Zoledronic acid-induced cutaneous B-cell pseudolymphoma. J. Am. Acad. Dermatol. 65(6), 1238–1240 (2011).
   PubMed Web of Science ®Google Scholar
• Choi Y, Kim SC. Cutaneous pseudolymphoma induced by Hirudo medicinalis therapy. J. Dermatol. 39(2), 195–197 (2012).
   PubMed Web of Science ®Google Scholar
• Flaig MJ, Rupec RA. Cutaneous pseudolymphoma in association with Leishmania donovani. Br. J. Dermatol. 157(5), 1042–1043 (2007).
   PubMed Web of Science ®Google Scholar
• Moreira E, Lisboa C, Azevedo F, Principe F, Lima M. Postzoster cutaneous pseudolymphoma in a patient with B-cell chronic lymphocytic leukaemia. J. Eur. Acad. Dermatol. Venereol. 21(8), 1112–1114 (2007).
   PubMed Web of Science ®Google Scholar
• Ploysangam T, Breneman DL, Mutasim DF. Cutaneous pseudolymphomas. J. Am. Acad. Dermatol. 38(6 Pt 1), 877–95; quiz 896–7 (1998).
   PubMed Web of Science ®Google Scholar
• Croce S, Lhermitte B, Tomasetto C, Guillard O, Bellocq JP, Chenard MP. [Late-onset vaccination-induced subcutaneous pseudolymphoma]. Ann. Pathol. 28(2), 146–149 (2008).
   PubMed Web of Science ®Google Scholar
• Barr-Nea L, Sandbank M, Ishay J. Pseudolymphoma of skin induced by oriental hornet (Vespa orientalis) venom. Experientia 32(12), 1564–1565 (1976).
   PubMedGoogle Scholar
• Szekeres L. [Foreign body reaction and pseudolymphoma of the skin. Possibilities of differential diagnosis of lymphomas]. Z Hautkr. 52(21), 1069–1077 (1977).
   PubMedGoogle Scholar
• Kalimo K, Rasanen L, Aho H, Maki J, Mustikkamki UP, Rantala I. Persistent cutaneous pseudolymphoma after intradermal gold injection. J. Cutan. Pathol. 23(4), 328–334 (1996).
   PubMed Web of Science ®Google Scholar
• Kim Y, Dawes-Higgs E, Mann S, Cook DK. Acral pseudolymphomatous angiokeratoma of children (APACHE). Australas. J. Dermatol. 46(3), 177–180 (2005).
   PubMedGoogle Scholar
• Bakels V, van Oostveen JW, Preesman AH, Meijer CJ, Willemze R. Differentiation between actinic reticuloid and cutaneous T cell lymphoma by T cell receptor gamma gene rearrangement analysis and immunophenotyping. J. Clin. Pathol. 51(2), 154–158 (1998).
   PubMed Web of Science ®Google Scholar
• Morgan MB, Stevens GL, and Switlyk S. Benign lichenoid keratosis: a clinical and pathologic reappraisal of 1040 cases. Am. J. Dermatopathol. 27(5), 387–392 (2005).
   PubMed Web of Science ®Google Scholar
• Browne G, Tobin B, Carney DN, Dervan PA. Aberrant MT2 positivity distinguishes follicular lymphoma from reactive follicular hyperplasia in B5- and formalin-fixed paraffin sections. Am. J. Clin. Pathol. 96(1), 90–94 (1991).
   PubMed Web of Science ®Google Scholar
• Barcos M. Mycosis fungoides. Diagnosis and pathogenesis. Am. J. Clin. Pathol. 99(4), 452–458 (1993).
   PubMed Web of Science ®Google Scholar
• Utz GL, Swerdlow SH. Distinction of follicular hyperplasia from follicular lymphoma in B5-fixed tissues: comparison of MT2 and bcl-2 antibodies. Hum. Pathol. 24(11), 1155–1158 (1993).
   PubMed Web of Science ®Google Scholar
• Ritter JH, Adesokan PN, Fitzgibbon JF, Wick MR. Paraffin section immunohistochemistry as an adjunct to morphologic analysis in the diagnosis of cutaneous lymphoid infiltrates. J. Cutan. Pathol. 21(6), 481–493 (1994).
   PubMed Web of Science ®Google Scholar
• Gronbaek K, Moller PH, Nedergaard T et al. Primary cutaneous B-cell lymphoma: a clinical, histological, phenotypic and genotypic study of 21 cases. Br. J. Dermatol. 142(5), 913–23 (2000).
   PubMed Web of Science ®Google Scholar
• Yang B, Tubbs RR, Finn W, Carlson A, Pettay J, Hsi ED. Clinicopathologic reassessment of primary cutaneous B-cell lymphomas with immunophenotypic and molecular genetic characterization. Am. J. Surg. Pathol. 24(5), 694–702 (2000).
   PubMed Web of Science ®Google Scholar
• Lawnicki LC, Weisenburger DD, Aoun P, Chan WC, Wickert RS, Greiner TC. The t(14;18) and bcl-2 expression are present in a subset of primary cutaneous follicular lymphoma: association with lower grade. Am. J. Clin. Pathol. 118(5), 765–772 (2002).
   PubMed Web of Science ®Google Scholar
• Hoefnagel JJ, Vermeer MH, Jansen PM, Fleuren GJ, Meijer CJ, Willemze R. Bcl-2, Bcl-6 and CD10 expression in cutaneous B-cell lymphoma: further support for a follicle centre cell origin and differential diagnostic significance. Br. J. Dermatol. 149(6), 1183–1191 (2003).
   PubMed Web of Science ®Google Scholar
• Shiozawa E, Yamochi-Onizuka T, Yamochi T et al. Disappearance of CD21-positive follicular dendritic cells preceding the transformation of follicular lymphoma: immunohistological study of the transformation using CD21, p53, Ki-67, and P-glycoprotein. Pathol. Res. Pract. 199(5), 293–302 (2003).
   PubMed Web of Science ®Google Scholar
• Wong HK, Mishra A, Hake T, Porcu P. Evolving insights in the pathogenesis and therapy of cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome). Br. J. Haematol. 155(2), 150–166 (2011).
   PubMed Web of Science ®Google Scholar
• Ghislanzoni M, Gambini D, Perrone T, Alessi E, Berti E. Primary cutaneous follicular center cell lymphoma of the nose with maxillary sinus involvement in a pediatric patient. J. Am. Acad. Dermatol. 52( 5 Suppl. 1), S73–S75 (2005).
   PubMed Web of Science ®Google Scholar
• de Leval L, Harris NL, Longtine J, Ferry JA, Duncan LM. Cutaneous b-cell lymphomas of follicular and marginal zone types: use of Bcl-6, CD10, Bcl-2, and CD21 in differential diagnosis and classification. Am. J. Surg. Pathol. 25(6), 732–741 (2001).
   PubMed Web of Science ®Google Scholar
• Kuzel TM, Roenigk HH Jr, Rosen ST. Mycosis fungoides and the Sezary syndrome: a review of pathogenesis, diagnosis, and therapy. J. Clin. Oncol. 9(7), 1298–1313 (1991).
   PubMed Web of Science ®Google Scholar
• Kodama K, Fink-Puches R, Massone C, Kerl H, Cerroni L. Papular mycosis fungoides: a new clinical variant of early mycosis fungoides. J. Am. Acad. Dermatol. 52(4), 694–698 (2005).
   PubMed Web of Science ®Google Scholar